AI Article Synopsis
- Primary effusion lymphoma (PEL) is a rare B-cell lymphoma often seen in HIV-infected patients, marked by fluid buildup without mass formation and associated with human herpesvirus 8 (HHV-8).
- A new type of lymphoma similar to PEL has been identified in non-HIV-infected patients, called HHV-8-unrelated PEL-like lymphoma, but its underlying mechanisms remain largely unclear.
- Researchers developed a new B-cell line, OGU1, from a patient with HHV-8-unrelated PEL-like lymphoma, which revealed that these cells produce vascular endothelial growth factor (VEGF), suggesting its potential role in the disease's progression.
Article Abstract
Primary effusion lymphoma (PEL) is a rare B-cell lymphoma subtype that is characterized by lymphomatous effusion without the presence of masses, and it typically occurs in human immunodeficiency virus (HIV)-infected individuals. Lymphoma cells are universally positive for human herpesvirus 8 (HHV-8). Recently, a cavity-based effusion lymphoma that is similar to PEL without HHV-8 infection, called HHV-8-unrelated PEL-like lymphoma, has been reported in non-HIV-infected individuals. However, the pathophysiology of this lymphoma is largely undefined. We established a novel B-cell line OGU1 derived from a patient with HHV-8-unrelated PEL-like lymphoma. Notably, OGU1 cells produced vascular endothelial growth factor (VEGF) and expressed VEGF receptor 1, whose inhibitors retarded cell growth. Because VEGF acts as a vascular permeability and growth factor, it could play a role, at least in part, in the pathogenesis of this unique lymphoma. Thus, the OGU1 cell line is useful for the investigation of HHV-8-unrelated PEL-like lymphoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ejh.12559 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Where has the lymphoma gone? Pericardial effusion adenosine deaminase may play a key role in diagnosing primary effusion lymphoma-like lymphoma: a case report.
Eur Heart J Case Rep
July 2023
Department of Internal Medicine, Hyogo Prefectural Tamba Medical Center, 2002-7, Hikami-cho Iso, Tamba, Hyogo 669-3495, Japan.
Background: Primary effusion lymphoma (PEL) is a non-Hodgkin lymphoma that is exclusively generated by body cavity effusion. Primary effusion lymphoma develops in patients infected with human immunodeficiency virus (HIV) and is associated with the human herpes virus (HHV)-8 infection. However, there are sporadic cases without HHV-8 infections or any history of immunodeficiency, called 'PEL-like lymphoma'.
View Article and Find Full Text PDFHHV8-unrelated primary effusion lymphoma in a patient with HBV-related liver cirrhosis: A case successfully treated with rituximab and lenalidomide.
Clin Case Rep
June 2023
Department Lymphoma, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) South Medical University Guangzhou China.
Human herpesvirus type 8 (HHV-8) unrelated primary effusion lymphoma (PEL) like lymphoma (PEL-LL) is an exceedingly rare non-Hodgkin lymphoma with no characteristic symptoms and consensus on the optimal treatment. This case report presents a 55-year-old man with prior HBV-related Child-Pugh B liver cirrhosis and developing activity-related dyspnea. A moderate amount of pleural effusion was identified without tumor masses, and cytological studies confirmed a diagnosis of PEL-LL.
View Article and Find Full Text PDFEBV-positive PEL-like lymphoma that developed in the course of antisynthetase syndrome treated with tacrolimus.
Int J Hematol
September 2018
Internal Medicine Department, Okayama Rousai Hospital, 1-10-25 Chikko, Midori-machi, Minamiku, Okayama city, Okayama, 702-8055, Japan.
Primary effusion lymphoma (PEL) is a rare type of extranodal lymphoma, typically of a B-cell origin, which presents as lymphomatous effusion with no nodal enlargement or tumor masses. The development PEL is universally associated with human herpes virus-8 (HHV-8) infection. Cases of HHV-8-negative primary lymphomatous effusion have recently been reported and referred to as HHV-8-unrelated PEL-like lymphoma.
View Article and Find Full Text PDFHHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q.
Sci Rep
March 2016
Department of Genetics, University of Leicester, Leicester, LE1 7RH, UK.
Primary effusion lymphomas (PEL) are associated with human herpesvirus-8 (HHV-8) and usually occur in immunocompromised individuals. However, there are numerous reports of HHV-8-unrelated PEL-like lymphomas with unknown aetiology. Here we characterize an HHV-8-unrelated PEL-like lymphoma in an elderly woman who was negative for human immunodeficiency viruses 1 and 2, and hepatitis B and C.
View Article and Find Full Text PDFHuman herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in the pericardium: A case with latency type III Epstein-Barr virus infection showing good prognosis without chemotherapy.
Pathol Res Pract
December 2015
Department of Pathology, The Institute of Medical Science, Research Hospital, The Tokyo University, Tokyo, Japan.
Primary effusion lymphoma (PEL) is a rare subtype of non-Hodgkin lymphoma that proliferates in body cavities without detectable masses. PEL is universally associated with human herpes virus-8 (HHV-8) infection and has an aggressive prognosis. Recently, an HHV-8-unrelated PEL-like lymphoma that usually occurs in elderly individuals and follows a more indolent prognosis has been reported, and it is treated as a disease distinct from PEL.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!